articles on home cleaning services customer service and defection automobile industry scholarly article best article writing topics how many md find writing scientific articles hard book college reviews article writing topics examples
EPA Approves Treating Orange Groves with Antibiotics
Environment, Featured Story, The Latest News

EPA Approves Treating Orange Groves with Antibiotics

Move Could Reduce the Effectiveness of Drugs Used to Combat Human Diseases

The Trump EPA recently approved spraying orange groves with an antibiotic used to treat a common sexually-transmitted disease. The move increases the risk that the antibiotic, oxytetracycline, might eventually not work to treat chlamydia and other human diseases.

People have until Feb. 4 to request hearings or raise objections about residue from this antibiotic on oranges and other citrus fruits.

“Researchers have been telling us for decades to curb the use of antibiotics in agriculture or risk losing them forever,” said Nathan Donley, a senior scientist with the Center for Biological Diversity. “The Trump administration has chosen to ignore the science and blindly sprint down a path that could dead-end at bacterial resistance.”

Oxytetracycline and similar antibiotics work by interfering with the ability of bacteria to grow and multiply. Florida orange growers have used the drug and another antibiotic, streptomycin, on an emergency basis against citrus greening, a disease with no cure that stunts the growth of oranges.

ACTION BOX/What You Can Do About It

Object or request a hearing by Feb. 4 about oxytetracycline residue on oranges. Directions are online. Formal objections or requests for a hearing should be sent to Office of the Hearing Clerk (1900L), Environmental Protection Agency, 1200 Pennsylvania Ave., NW, Washington, DC 20460-0001.

Comment online by Jan. 19 about expanding spraying of streptomycin.

Call EPA Acting Administrator Andrew Wheeler at 202-564-4700 to tell him your thoughts about using antibiotics on oranges or write to him at EPA Headquarters / William Jefferson Clinton Building / 1200 Pennsylvania Ave., NW / Mail Code:1101A / Washington, D.C. 20460

The Center for Biological Diversity can be reached at 520-623-5252 or [email protected].

The group of antibiotics that includes oxytetracycline once worked on a wider range of infections than penicillin, but antibiotic resistance now largely limits them to treat acne and chlamydia, a sexually transmitted disease that often has no symptoms and can cause infertility.

The rate of chlamydia increased by 6.9% from 2016 to 2017, the most recent figures available. The state with the highest rate of chlamydia is Alaska with almost 800 cases per 100,000 people. The rate in the District of Columbia is even higher, 1,337 cases per 100,000 people. The rate of reported chlamydia cases in women is about twice as high as the rate in men.

Oxytetracycline was once widely used to treat gonorrhea, another common sexually transmitted disease that may not have symptoms. The drug no longer works well because of antibiotic resistance. Gonorrhea cases were up 67% in 2017 compared with five years ago.

AgroSource Inc., one of the companies involved in distributing the antibiotic for use on oranges, lists its address in Florida records as a home in an expensive Palm Beach County neighborhood where Olivia Newton-John once lived. The agent for AgroSource is Taw Richardson.

The EPA could also approve spraying more than 650,000 pounds of streptomycin, another antibiotic distributed by AgroSource, on citrus groves in Florida each year. This would be more than 46 times the amount of similar antibiotics that Americans take each year to combat diseases. Streptomycin is commonly used to treat tuberculosis.

At least 2 million people in our nation fall ill each year from bacteria that are resistant to antibiotics. At least 23,000 of those people die.

The European Union and Brazil have banned using oxytetracycline and streptomycin as pesticides on agricultural fields.

Featured image: Florida oranges infected with citrus greening, a.k.a huanglongbing or yellow dragon disease.

January 17, 2019